P5650Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling | Zendy

AI Assistant Blog Pricing

P5650Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.